With multi-resistant germs becoming more and more of a threat, we are in need of new antibiotics now more than ever. Unfortunately, antibiotics cannot distinguish between pathogens and beneficial microbes. They can destroy the delicate balance of the microbiome – resulting in permanent damages. The research team around chemist Dr Thomas Böttcher has now made a significant step towards solving these problems. In collaboration with the team around biologist Professor Christof Hauck, also from Konstanz, the researchers discovered antibiotic properties of a natural product that so far had been considered merely a bacterial signal molecule. The team, including the doctoral researchers Dávid Szamosvári and Tamara Schuhmacher, developed and investigated synthetic derivatives of the natural substance that proved surprisingly efficient against the pathogen Moraxella catarrhalis. In the process only the growth of these pathogens was inhibited, not the growth of other bacteria. In a further project, the researchers succeed in developing another selective agent to combat the malaria parasite. These results might lead to a new basis for novel precision antibiotics. The research results are published in the current editions of the journals Chemical Science and Chemical Communications.
As important as antibiotics are to treat infectious diseases, they leave a trail of destruction in the human microbiome. Gastrointestinal disorders following antibiotic treatments are one of the slightest problems in this context. Quite often, resistant pathogens replace beneficial microbes. Later on, these can cause severe infectious diseases or chronic illnesses. However, not all microbes are dangerous. On the contrary, many microorganisms live in peaceful coexistence with us, and are even vital for human health. We humans are true microcosms and host more microbes than human cells. Yet this ecosystem, the human microbiome, is fragile. Allergies, overweight, chronic inflammatory bowel diseases and even psychiatric disorders may be the result of a damaged microbiome. The question is how can we maintain this ecological diversity in case of a microbial infection?
The research team originally studied the signals of the bacterium Pseudomonas aeruginosa. A compound aroused their interest as it was highly selectively inhibiting the growth of the pathogen Moraxella catarrhalis. This pathogen causes, for example, otitis media in children as well as infections in patients with chronically obstructive pulmonary diseases. The synthetic scaffold engineering of this natural product resulted in a new compound class with enormous antibiotic efficiency. What was really surprising was the substance’s selectivity: Only the growth of Moraxella catarrhalis was inhibited, not that of other bacteria. Even closely related bacteria from the same species remained completely unaffected.
Currently, Thomas Böttcher and Christof Hauck are investigating the mechanism of action of this highly selective antibiotic against the pathogen Moraxella catarrhalis. Antibiotics with such selectivity would make precision treatment possible and specifically eliminate pathogens while preserving the diversity of beneficial microbes.
Learn more: Selective antibiotics following nature’s example
The Latest on: Precision antibiotics
via Google News
The Latest on: Precision antibiotics
- With little to go on, Stanford Medicine's ICU task force forged ahead in COVID-19 fighton June 23, 2020 at 11:09 am
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
- Microsoft Azure and Johns Hopkins Medicine have partnered to accelerate precision medicineon June 23, 2020 at 6:31 am
Microsoft Azure and Johns Hopkins Medicine partnered to leverage Microsoft's AI and analytics tools to facilitate precision medicine breakthroughs.
- Assessment of COVID-19's Effect on Precision Medicine Software Market 2020-2024 | Benefits of Precision Medicine to Augment Growth | Technavioon June 22, 2020 at 1:15 pm
Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report The ...
- New class of precision medicine strips cancer of its DNA defenseson June 22, 2020 at 1:02 pm
A new precision medicine targeting cancer's ability to repair its DNA has shown promising results in the first clinical trial of the drug class.
- Roadmap for precision medicine in diabetes careon June 22, 2020 at 10:06 am
A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The ...
- Global Precision Medicine Market 2020 Analysis by Manufacturers, End-User, Type, Application, Regions and Forecast to 2026on June 21, 2020 at 8:54 pm
The purpose of this latest market research study titled Global Precision Medicine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 is to provide a comprehensive and ...
- Amid COVID-19, telehealth may help advance precision medicineon June 19, 2020 at 8:20 am
However, the COVID-19 pandemic has forced telehealth into the mainstream and it might just be the push we needed to bring the benefits of precision medicine to more patients. Reports show that the U.S ...
- Global Tumor Genomics Market (2019 to 2028) - Growing Prominence for Precision Medicine Presents Lucrative Opportunities - ResearchAndMarkets.comon June 19, 2020 at 6:59 am
The "Global Tumor Genomics Market: Focus on Products, Techniques, Applications, End User, Cancer Type, 14 Countries Data, Industry Insights and Competitive Landscape - Analysis and Forecast, 2019-2028 ...
- Former Packers RB Samkon Gado makes move from NFL to medicine with surgical precisionon June 18, 2020 at 6:43 am
Former Packers running back Samkon Gado is treating coronavirus patients and soaring toward his goal of being a surgeon in his native Nigeria.
- GNS Healthcare and Multiple Myeloma Research Foundation (MMRF) Announce a Five-Year Collaboration to Advance Precision Medicineon June 18, 2020 at 5:18 am
"The MMRF has had a tremendous impact on the field and on patients through their data and precision medicine stewardship. As we embark on building the next generation of in silico patient computer ...
via Bing News